Cargando…
Measuring What Matters to Individuals with Angelman Syndrome and Their Families: Development of a Patient-Centered Disease Concept Model
Angelman syndrome (AS) is a complex, heterogeneous, and life-long neurodevelopmental disorder. Despite the considerable impact on individuals and caregivers, no disease-modifying treatments are available. To support holistic clinical management and the development of AS-specific outcome measures for...
Autores principales: | Willgoss, Tom, Cassater, Daiana, Connor, Siobhan, Krishnan, Michelle L., Miller, Meghan T., Dias-Barbosa, Carla, Phillips, Dawn, McCormack, Julie, Bird, Lynne M., Burdine, Rebecca D., Claridge, Sharon, Bichell, Terry Jo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238699/ https://www.ncbi.nlm.nih.gov/pubmed/32880036 http://dx.doi.org/10.1007/s10578-020-01051-z |
Ejemplares similares
-
A placebo-controlled trial of folic acid and betaine in identical twins with Angelman syndrome
por: Han, Julia, et al.
Publicado: (2019) -
Angelman syndrome: review of clinical and molecular aspects
por: Bird, Lynne M
Publicado: (2014) -
Healthcare burden among individuals with Angelman syndrome: Findings from the Angelman Syndrome Natural History Study
por: Khan, Nasreen, et al.
Publicado: (2019) -
Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairment
por: Keute, Marius, et al.
Publicado: (2020) -
Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)
por: Tjeertes, Jorrit, et al.
Publicado: (2023)